Chuang Yi Biotech co., ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 78.44 million compared to TWD 73.05 million a year ago. Revenue was TWD 70.97 million compared to TWD 70.02 million a year ago.

Net loss was TWD 20.21 million compared to TWD 19.34 million a year ago. Basic loss per share from continuing operations was TWD 1.33 compared to TWD 1.28 a year ago. Diluted loss per share from continuing operations was TWD 1.33 compared to TWD 1.28 a year ago.